Acute liver failure secondary prevention: Difference between revisions
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Effective measures for secondary prevention of acute liver failure include management of chronic liver disease and its complications. In patients with resolved hepatitis B infection, antiviral prophylaxis can be considered in the patients who have a risk of reactivation such as during increasing levels of immunosuppression. | |||
==Secondary Prevention== | ==Secondary Prevention== |
Revision as of 19:47, 30 November 2017
Acute liver failure Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acute liver failure secondary prevention On the Web |
American Roentgen Ray Society Images of Acute liver failure secondary prevention |
Risk calculators and risk factors for Acute liver failure secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Effective measures for secondary prevention of acute liver failure include management of chronic liver disease and its complications. In patients with resolved hepatitis B infection, antiviral prophylaxis can be considered in the patients who have a risk of reactivation such as during increasing levels of immunosuppression.
Secondary Prevention
Effective measures for secondary prevention of acute liver failure include:[1]
- Management of chronic liver disease appropriately.
- Management of active complications of the chronic liver disease.
- In patients with resolved hepatitis B infection, antiviral prophylaxis can be considered in the patients who have risk of reactivation such as during increasing levels of immunosuppression.
References
- ↑ Karvellas CJ, Cardoso FS, Gottfried M, Reddy KR, Hanje AJ, Ganger D; et al. (2017). "HBV-Associated Acute Liver Failure After Immunosuppression and Risk of Death". Clin Gastroenterol Hepatol. 15 (1): 113–122. doi:10.1016/j.cgh.2016.06.008. PMID 27311622.